Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced it will host an analyst and investor education webcast at 2:00 PM Eastern Time on Tuesday, June 25, 2024, focusing on clinical developments in ultra-low-field (ULF) MR imaging.
- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced it will host an analyst and investor education webcast at 2:00 PM Eastern Time on Tuesday, June 25, 2024, focusing on clinical developments in ultra-low-field (ULF) MR imaging.
- The event will be moderated by Edmond Knopp, MD, Hyperfine, Inc. VP of Medical Affairs.
- Dr. Knopp will interview several key opinion leaders on using the Swoop® system in critical care, stroke, and dementia, including Alzheimer’s treatment workflows.
- Jamal Derakhshan, MD, PhD, Neuroradiologist and MR Medical Director from Jefferson Abington Hospital, to discuss their experience adopting the Swoop® system.